William Blair Weighs in on Beauty Health FY2024 Earnings

The Beauty Health Company (NASDAQ:SKIN) – Equities research analysts at William Blair issued their FY2024 earnings estimates for Beauty Health in a research note issued to investors on Wednesday, November 13th. William Blair analyst M. Andrew expects that the company will post earnings of ($0.29) per share for the year. The consensus estimate for Beauty Health’s current full-year earnings is ($0.25) per share. William Blair also issued estimates for Beauty Health’s FY2025 earnings at ($0.43) EPS.

Several other research analysts have also recently issued reports on SKIN. Canaccord Genuity Group increased their price objective on Beauty Health from $1.25 to $1.75 and gave the stock a “hold” rating in a research report on Wednesday, November 13th. Stifel Nicolaus reduced their price objective on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating for the company in a research note on Friday, July 26th. Finally, Piper Sandler restated an “underweight” rating and set a $1.00 target price (down from $1.50) on shares of Beauty Health in a research report on Friday, August 9th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $2.55.

Beauty Health Stock Performance

Shares of SKIN stock opened at $1.62 on Monday. The company has a current ratio of 6.56, a quick ratio of 5.57 and a debt-to-equity ratio of 9.23. The stock has a 50 day simple moving average of $1.58 and a 200-day simple moving average of $1.84. The company has a market cap of $200.29 million, a price-to-earnings ratio of -3.85 and a beta of 0.90. Beauty Health has a 12-month low of $0.91 and a 12-month high of $5.17.

Hedge Funds Weigh In On Beauty Health

Several hedge funds have recently added to or reduced their stakes in SKIN. SG Americas Securities LLC acquired a new stake in shares of Beauty Health in the third quarter valued at approximately $37,000. Caprock Group LLC purchased a new stake in Beauty Health in the 2nd quarter valued at approximately $38,000. Sanctuary Advisors LLC acquired a new stake in Beauty Health during the 2nd quarter valued at $47,000. Orion Portfolio Solutions LLC acquired a new position in shares of Beauty Health in the third quarter worth $65,000. Finally, Susquehanna Fundamental Investments LLC purchased a new stake in shares of Beauty Health in the second quarter valued at $105,000. 93.26% of the stock is currently owned by hedge funds and other institutional investors.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.